Califf Nomination Gets Fishy With Murkowski Hold
This article was originally published in The Rose Sheet
Executive Summary
Senator Murkowski promises a hold on Robert Califf’s nomination for FDA commissioner over the agency’s approval of genetically engineered salmon.
You may also be interested in...
PDUFA Reaches Approval Altitude; Can House Maintain Senate Speed?
After about a week of debate, the Senate overwhelmingly passes its FDA user fee package, with only track and trace to be finalized. House members are scheduled to begin floor debate after Memorial Day in the hopes of sending the bill to President Obama before July 4.
FDA Commissioner Nominee's Finances Are More Complicated In Second Confirmation Process
Robert Califf has industry connections, just like during his previous confirmation to lead the US FDA, but they are different now, as he holds several board seats in addition to a full-time position at a health care tech company.
How Star Wars Explains Biosimilar Labeling Problems
US FDA largely writes biosimilar labels that are the same as their reference products even though it’s not required, which could hinder product development and uptake, experts say.